InvestorsHub Logo
Followers 1039
Posts 116315
Boards Moderated 12
Alias Born 06/10/2006

Re: None

Monday, 10/05/2009 6:08:36 PM

Monday, October 05, 2009 6:08:36 PM

Post# of 44409
Todays News. Cardio Infrared Phase II Clinical Trials to be Completed This Year

LAS VEGAS, Oct. 5, 2009 (GLOBE NEWSWIRE) -- Cardio Infrared Technologies, Inc. (Pink Sheets:CDOI - News) (www.cardio-cor.com), a leading Health and Wellness technology and marketing company, announced today that the clinical trials being conducted in Pennsylvania completed Phase I earlier this year and demonstrated the efficacy portion of the trials. Phase II, which has been underway for 6 months, has been testing the effects on Detoxification and will be available by the end of this year.

Wayne Bailey, President and CEO of Cardio Infrared Technologies, Inc., stated: "The second phase of the clinical trials are within two months of completion. The expanded number of people involved in the second phase is providing a tremendous amount of additional information and data on the Cardio-Cor system. The results from the expanded Phase II are reported to be superior to those released in the first phase and additional levels of study are showing amazing results according to the community of patients involved. The expanded basis of the second phase of the study is concerned not only with weight and inch loss but also on detoxification and the tested results of infrared on the body. The report on the second phase is scheduled to be completed before the Las Vegas Anti-Aging show in December. The third phase of the Clinicals will be a comparison of the Cardio-Cor ExerBike vs. a treadmill which will document the additional benefits of using the Cardio-Cor over any other type of exercise equipment available to the public."

The clinical trials that were completed in Italy will also be released within the next three months. The Clinicals from Italy were completed using Italian guidelines, not FDA standards. They show vast weight, inch and cellulite loss. They also address detoxification and many of the other issues that our Phase II study is now addressing. The release of the additional studies will add validity to the technology and products of Cardio Infrared Technologies.


SURFKAST

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.